A magnifying glass onto renal function and serum lipid evolutions after tenofovir (TDF) and emtricitabine (FTC) in combination with atazanavir/ritonavir (ATV/r) versus efavirenz (EFV) as first‐line HAART (the INCA trial)

Authors :: Izzo, I
Albini, L
Calabresi, A
Motta, D
Bellagamba, R
Fezza, R
Narciso, P
Sighinolfi, L
Maggi, P
Focà, E
Mendeni, M
Manili, L
Magoni, M
Carosi, G
Quiros?Roldan, E
Torti, C
Source :: Journal of the International AIDS Society. November, 2010, Vol. 13, p85, 2 p.
Publication Year :: 2010
Abstract: 7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK<br />Background Measures of glomerular filtration rate (GFR) showed discordant results. CKD‐EPI creatinine formula resulted more accurate than other equations in subjects with normal or mildly decreased renal function in the [...]

Subjects :: Efavirenz -- Dosage and administration -- Testing
Ritonavir -- Testing -- Dosage and administration
Highly active antiretroviral therapy -- Testing
Atazanavir -- Dosage and administration -- Testing
Blood lipids -- Health aspects -- Measurement
Glomerular filtration rate -- Measurement
Emtricitabine -- Dosage and administration -- Testing
HIV infection -- Drug therapy
Health

Full Text Access

Tools